Investegate announcements from Pixium Vision, Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022
Pixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022 The target number of 38 patients have
Uveitis, a rare inflammatory eye illness, is responsible for five to ten percent of blindness worldwide. In particular, posterior uveitis is frequently associat
New diagnostic option for rare eye disease miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.